Directorio de personas
Felipe Vilardell Villellas

Felipe Vilardell Villellas

Grado: Doctor/a


fvilardell.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/B-8141-2015

Publicaciones

  • Ortiz-Brugues, A; Marti-Laborda, RM; Azon-Masoliver, A; Vilardell-Vilellas, F; Casanova-Seuma, JM

    Lymphoproliferative CD30-positive disorder in a patient with a folliculotropic mycosis fungoides

    Journal Der Deutschen Dermatologischen Gesellschaft 15 577-579. .

    [doi:10.1111/ddg.12569]

  • Huerva, V; Traveset, AE; Vilardell, F

    Topical Interferon Alpha-2b for Diffuse Conjunctival Primary Acquired Melanosis with Atypia

    Ocular Immunology And Inflammation 25 284-286. .

    [doi:10.3109/09273948.2015.1115880]

  • Gasol Cudos, A.; Morales Murillo, S.; Panades Siurana, M. J.; Vilardell Villellas, F.; Canosa Morales, C.; Mele Olive, J.; Iglesias Martinez, E.; Salud Salvia, A.

    Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution

    BREAST 32 92-93. .

  • Moreno, R; Rojas, LA; Villellas, FV; Soriano, VC; Garcia-Castro, J; Fajardo, CA; Alemany, R

    Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus

    Stem Cells International 2017 3615729-3615729. .

    [doi:10.1155/2017/3615729]

  • Mirantes, C; Dosil, MA; Hills, D; Yang, J; Eritja, N; Santacana, M; Gatius, S; Vilardell, F; Medvinsky, A; Matias-Guiu, X; Dolcet, X

    Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies

    Blood 127 1907-1911. .

    [doi:10.1182/blood-2015-09-669036]

  • García de la Fuente MR; Vilardell-Villellas F; Martí-Laborda RM; Casanova-Seuma JM

    Primary cutaneous small-to-medium-sized CD4+ T-cell lymphoma with a granulomatous component

    ACTAS DERMO-SIFILIOGRAFICAS 107 86-88. .

    [doi:10.1016/j.ad.2015.04.018]

  • Gas-Ruiz C; Ros-López SE; Vilardell-Villella F; Mias-Carballal C; Villalobos-Mori R; De-la-Fuente-Juárez MC; Baena-Fustegueras JA; Olsina-Kissler JJ

    Lethal pseudomembranous colitis in an immunocompetent patient.

    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 107 117-119. .

  • Papis, D.; Branchi, V.; Gomez, L.; Herrerias, F.; Vilardell, F.; Gonzalez, M.; Olsina, J.J.

    Abdominal tuberculosis mimicking Crohn's disease's exacerbation: A clinical, diagnostic and surgical dilemma. A case report

    International Journal of Surgery Case Reports 6 122-125. .

    [doi:10.1016/j.ijscr.2014.11.075]

  • García-Carbonero R; Vilardell F; Jiménez-Fonseca P; González-Campora R; González E; Cuatrecasas M; Capdevila J; Aranda I; Barriuso J; Matías-Guiu X

    Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    CLINICAL & TRANSLATIONAL ONCOLOGY 16 243-256. .

    [doi:10.1007/s12094-013-1062-9]

  • Barcelo C; Paco N; Morell M; Alvarez-Moya B; Bota-Rabassedas N; Jaumot M; Vilardell F; Capella G; Agell N

    Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth

    CANCER RESEARCH 74 1190-1199. .

    [doi:10.1158/0008-5472.CAN-13-1750]

  • Gomez-Martin C; Plaza JC; Pazo-Cid R; Salud A; Pons F; Fonseca P; Leon A; Alsina M; Visa L; Rivera F; Galan MC; Del Valle E; Vilardell F; Iglesias M; Fernandez S; Landolfi S; Cuatrecasas M; Mayorga M; Jose Paulés M; Sanz-Moncasi P; Montagut C; Garralda E; Rojo F; Hidalgo M; Lopez-Rios F

    Level of HER2 Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab

    Journal of Clinical Oncology 31 4445-4445. .

    [doi:10.1200/JCO.2013.48.9070]

  • Peg V; Espinosa-Bravo M; Vieites B; Vilardell F; Antúnez JR; de Salas MS; Delgado-Sánchez JJ; Pinto W; Gozalbo F; Petit A; Sansano I; Del Mar Téllez M; Rubio IT

    Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients

    BREAST CANCER RESEARCH AND TREATMENT 139 87-93. .

    [doi:10.1007/s10549-013-2524-z]

Proyectos

  • Análisis del microambiente tumoral del melanoma cutáneo asociado al perfil genético y/o a la aparición de resistencias
  • Development of precision therapies for triple negative breast cancer based on CRISPR/Cas12a ribonucleoproteins
  • Análisis del secretoma en el melanoma humano asociado al perfil genético y a la aparición de resistencias. Identificación de biomarcadores y/o dianas terapéuticas de aplicación clínica
  • POSTDOCTORAL AECC 2017: ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA HUMANO. ESTUDIO DE LAS RESISTENCIAS A FARMACOS CONVENCIONALES Y EL PROCESO AUTOFAGICO
  • ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
  • Carcinoma de endometrio. Participación de las vías de señalización, implicadas en la resistencia a la terapia antineoplasica
  • CONTRATOS POSTDOCTORALES DE PERFECCIONAMIENTO SARA BORRELL